Fig. 1 · Structure

Documents & Downloads

U-69593

Cat. No. A14187 CAS 96744-75-1

κ1-opioid receptor agonist

U-69593 is a potent, selective κ1-opioid receptor agonist (EC50 = 80-109 nM). Active in vivo. Antinociceptive.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
CHO IC50 0.63 nM Binding affinity against rat kappa-opioid receptor expressed in CHO cells was determined by competitive inhibition of 2 nM [3H]-U 69593 [PMID: 9873480]
CHO EC50 0.8 nM Agonist activity at human KOR expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by luminescence assay [PMID: 25426797]
CHO EC50 12.5 nM Agonist activity at human recombinant kappa opioid receptor expressed in CHO cells assessed as calcium mobilization after 1 hrs by fluorescence analysis [PMID: 22464684]
CHO EC50 207 nM Agonist activity at human kappa opioid receptor expressed in CHO cells by [35S]GTPgammaS binding [PMID: 16441078]
CHO EC50 207 nM Antagonist activity at human kappa opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay [PMID: 17580847]
CHO EC50 26.1 nM Agonist activity at human kappa opioid receptor expressed in CHO cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay [PMID: 23134120]
CHO EC50 28.1 nM Agonist activity at human recombinant kappa opioid receptor expressed in CHO cells after 2 hrs by [35S]-GTPgammaS binding assay [PMID: 23200250]
CHO EC50 28.1 nM Agonist activity at human KOR expressed in CHO cell membranes by [35S]GTPgammaS binding assay [PMID: 26346669]
CHO EC50 28.1 nM Agonist activity at human kappa opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay [PMID: 25283554]
CHO EC50 6.6 nM Agonist activity at human kappa opioid receptor-Galpha-16 fusion protein expressed in CHO cells by calcium flux assay [PMID: 16441078]
CHO EC50 60.14 nM Agonist activity at human kappa opioid receptor transfected in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis [PMID: 24657054]
CHO EC50 7.7 nM Agonist activity at rat kappa opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay [PMID: 25221662]
CHO EC50 8.03 nM Agonist activity at human KOR expressed in CHO cells by [35S]GTPgammaS binding assay [PMID: 25248680]
HEK293 EC50 12 nM Agonist activity at human kappa opioid receptor expressed in HEK-293 cells assessed as stimulation of [35S]-GTPgammaS binding after 30 mins by liquid scintillation counting analysis [PMID: 25062506]
HEK293 EC50 12 nM Agonist activity at human kappa opioid receptor expressed in HEK-293 cells after 45 mins by [35S]GTP-gamma-S binding assay in presence of 10 uM of GDP 10.1039/C5MD00414D
HEK293 ED50 24 nM Effective dose for agonistic activity towards human kappa opioid receptor from membranes of HEK293 cells was determined by radiolabeled [35S]GTP-gamma-S, assay [PMID: 12643930]
HEK293 EC50 5.3 nM Agonist activity at recombinant human kappa-type opioid receptor expressed in HEK293 cells after 30 mins by [35S]GTPgammaS binding assay [PMID: 28218838]
HEK293 EC50 534 nM Agonist activity at GFP-fused kappa opioid receptor (unknown origin) expressed in HEK293 cells assessed as recruitment of beta-arrestin-2 after 10 mins by BRET assay [PMID: 24613457]
HEK293 EC50 80 nM Agonist activity at human recombinant kappa opioid receptor expressed in HEK293 cells assessed as stimulation of [35S]GTPgammaS binding after 45 mins by microplate luminescence assay [PMID: 20441176]

19 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Agonist
CAS Number 96744-75-1
Applications κ1-opioid receptor agonist
Formula C22H32N2O2
Molecular Weight 356.5
SMILES
CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N3CCCC3)C(=O)CC4=CC=CC=C4

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...